Number of the records: 1  

A dark side to NS1 antibodies?

  1. 1.
    0554924 - BC 2023 RIV US eng O - Others
    Robbiani, D.F. - Růžek, Daniel
    A dark side to NS1 antibodies?
    2021. Journal of Experimental Medicine. Rockefeller University Press. Roč. 218, č. 9 (2021), č. článku e20211348. ISSN 0022-1007. E-ISSN 1540-9538
    R&D Projects: GA ČR(CZ) GA20-14325S; GA ČR(CZ) GF21-05445L
    Institutional support: RVO:60077344
    Keywords : monoclonal-antibodies
    OECD category: Immunology
    Method of publishing: Open access
    https://rupress.org/jem/article/218/9/e20211348/212515/A-dark-side-to-NS1-antibodies-A-dark-side-to-NS1

    The NS1 protein of flaviviruses is taking center stage. Recent work has made it an attractive target for development of vaccines and immunotherapeutics. Cavazzoni and colleagues (2021. J. Exp. Med. https://doi.org/10.1084/jem. 20210580) now reveal a dark side to NS1, linking it to the development of self-reactive antibodies.
    Permanent Link: http://hdl.handle.net/11104/0329541

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.